NCT03325296View on ClinicalTrials.gov

Efficacy of Twice Daily Application of LEO 124249 Ointment 30 mg/g for 12 Weeks on Eyebrow Alopecia Areata.

PHASE2TerminatedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

October 30, 2017

Primary Completion Date

May 16, 2018

Study Completion Date

May 16, 2018

Conditions
Alopecia Areata
Interventions
DRUG

LEO 124249

Ointment containing LEO 124249

OTHER

Ointment vehicle

Ointment without active ingredients

Trial Locations (2)

2820

Investigational site, Gentofte Municipality

8000

Investigational site, Aarhus

Sponsors

Lead Sponsor

LEO Pharma
All Listed Sponsors
lead

LEO Pharma

INDUSTRY